• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

Recent Advances in the Study of 1-[1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-4-yl]-Ethanone (CAS: 5078-59-1)

In recent years, the compound 1-[1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-4-yl]-Ethanone (CAS: 5078-59-1) has garnered significant attention in the field of chemical biology and pharmaceutical research. This pyrazole derivative has shown promising potential in various therapeutic applications, including anti-inflammatory, antimicrobial, and anticancer activities. The latest studies have focused on elucidating its molecular mechanisms, optimizing its synthesis, and exploring its pharmacological properties.

A recent study published in the *Journal of Medicinal Chemistry* investigated the anti-inflammatory effects of 1-[1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-4-yl]-Ethanone. The researchers demonstrated that this compound effectively inhibits the production of pro-inflammatory cytokines such as TNF-α and IL-6 in vitro. The study also highlighted its potential as a lead compound for developing novel anti-inflammatory drugs with fewer side effects compared to existing therapeutics.

Another significant advancement comes from a 2023 study in *Bioorganic & Medicinal Chemistry Letters*, which explored the antimicrobial properties of this compound. The research team synthesized several analogs of 1-[1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-4-yl]-Ethanone and evaluated their efficacy against a panel of drug-resistant bacterial strains. The results indicated that certain derivatives exhibited potent antibacterial activity, particularly against methicillin-resistant *Staphylococcus aureus* (MRSA).

In the realm of oncology, a groundbreaking study published in *Cancer Research* revealed that 1-[1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-4-yl]-Ethanone induces apoptosis in cancer cells by modulating the PI3K/AKT signaling pathway. The compound was shown to selectively target cancer cells while sparing normal cells, suggesting its potential as a targeted therapy for certain types of cancer. Further preclinical studies are underway to validate these findings.

The synthesis and optimization of 1-[1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-4-yl]-Ethanone have also been a focal point of recent research. A study in *Tetrahedron Letters* presented a novel, high-yield synthetic route for this compound, which could facilitate its large-scale production for further pharmacological evaluation. The improved synthesis method reduces the use of hazardous reagents and enhances the overall efficiency of the process.

In conclusion, the compound 1-[1-(2-hydroxyethyl)-5-methyl-1H-pyrazol-4-yl]-Ethanone (CAS: 5078-59-1) continues to be a subject of intense research due to its diverse pharmacological properties. Recent studies have shed light on its mechanisms of action, therapeutic potential, and synthetic improvements. These advancements pave the way for future drug development efforts and highlight the importance of this compound in the field of chemical biology and pharmaceutical sciences.

• 933454-80-9(1-(3-Methyl-1-propyl-1H-pyrazol-4-yl)ethanone)
• 956951-04-5(1-(5-Methyl-1-propyl-1H-pyrazol-4-yl)ethanone)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)